Adjunctive xanomeline/trospium in clozapine-resistant schizophrenia: two case reports demonstrating limited response

Few pharmacologic options exist for patients with clozapine-resistant schizophrenia (CRS) or schizoaffective disorder. Xanomeline/trospium represents a new class of antipsychotic medication that has efficacy as monotherapy for schizophrenia. Despite distinct mechanistic differences from standard ant...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Vanessa M. Dang, John M. Powers, Matej Markota, Jonathan G. Leung
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	SAGE Publishing 2026-03-01
Schriftenreihe:	Therapeutic Advances in Psychopharmacology
Online-Zugang:	https://doi.org/10.1177/20451253261433832
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!